A vaccine targeting gonorrhea will soon be rolled out on the NHS. This will make England and Wales the first two countries in ...

Research has shown that the 4CMenB vaccine provides some protection against an infection from the Neisseria gonorrhoeae ...

The Swiss drugmaker says the safety and efficacy of zosurabalpin will be investigated in a study involving 400 patients with ...

Debiopharm initially received funding from CARB-X in 2017 for pre-clinical development of Debio1453, which inhibits an ...

Debiopharm ( a privately-owned, Swiss-based biopharmaceutical company aiming to establish tomorrow’s standard-of-care to cure ...

England will be the first country to offer a gonorrhoea vaccine to high-risk groups, as cases hit record highs and resistance ...

Research conducted by the Joint Committee on Vaccination and Immunisation (JCVI) indicates that the new vaccine is 32.7% to ...

A world-first vaccine for gonorrhoea is being rolled out in England after the number of cases hit record highs. The number of ...

A vaccine for gonorrhoea will be rolled out in England as part of a world-first programme, officials have announced.

Thousands of gonorrhoea cases could be prevented over the next decade thanks to the NHS’ world-first vaccination programme against the infection. Eligible patients, which includes gay and bisexual men ...

A new vaccine for gonorrhoea is to be rolled out by the NHS in England to tackle a rise in antibiotic-resistant “super” ...